Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Forte Biosciences is a biotechnology company that focuses on dermatology.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Congruence Therapeutics operates as a biotechnology company.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
TELA Bio is a life science company that specializes in soft tissue reconstruction.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
OrbiMed has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Biopharma. The firm invests across 18 different industry categories.
Among tracked funding rounds, Terns Pharmaceuticals received $650.0M in a Post-IPO Equity round. OrbiMed's total known invested capital is $31.2B.
OrbiMed's average investment size is $108.2M across its portfolio of 288 companies.
Recent OrbiMed portfolio additions include Forte Biosciences, Sidewinder Therapeutics, Apollomics, Pinnacle Medicines, Congruence Therapeutics. These companies were founded in 2020 or later.